Correlations between clinical state, histology and immunological responsiveness in patients with prostatic cancer.
D000368:Aged; D002570:Ceruloplasmin / Q000032:analysis; D003176:Complement C3 / Q000032:analysis; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011470:Prostatic Hyperplasia / Q000276:immunology / Q000473:pathology*; D011471:Prostatic Neoplasms / Q000276:immunology / Q000473:pathology*; D014168:Transferrin / Q000032:analysis; D000515:alpha 1-Antitrypsin / Q000032:analysis
D003176:Complement C3; D007074:Immunoglobulin G; D014168:Transferrin; D000515:alpha 1-Antitrypsin; D002570:Ceruloplasmin